Corrigendum to ‘Benefits and Safety of Periprocedural Heparin During Thrombectomy in Patients Contra-Indicated for Alteplase’ [Journal of Stroke and Cerebrovascular Diseases, Vol. 29, No. 10 (October), 2020: 105052] - Université de Lorraine Accéder directement au contenu
Article Dans Une Revue Journal of Stroke and Cerebrovascular Diseases Année : 2021

Corrigendum to ‘Benefits and Safety of Periprocedural Heparin During Thrombectomy in Patients Contra-Indicated for Alteplase’ [Journal of Stroke and Cerebrovascular Diseases, Vol. 29, No. 10 (October), 2020: 105052]

Sébastien Richard

Dates et versions

hal-03280247 , version 1 (07-07-2021)

Identifiants

Citer

Solène Hebert, Pierre Clavel, Benjamin Maier, Katsuhiro Mizutani, François Delvoye, et al.. Corrigendum to ‘Benefits and Safety of Periprocedural Heparin During Thrombectomy in Patients Contra-Indicated for Alteplase’ [Journal of Stroke and Cerebrovascular Diseases, Vol. 29, No. 10 (October), 2020: 105052]. Journal of Stroke and Cerebrovascular Diseases, 2021, 30 (2), pp.105465. ⟨10.1016/j.jstrokecerebrovasdis.2020.105465⟩. ⟨hal-03280247⟩
21 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More